Table 2 Demographic and baseline disease characteristics of the SSc patients
From: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
|  | Overall (N = 88) |
|---|---|
Age, years, mean (SD) | 49 (13) |
Female, N (%) | 66 (75%) |
White, N (%) | 72 (82%) |
Not Hispanic or Latino, N (%) | 76 (86%) |
Disease duration, years*, mean (SD) | 1.59 (0.81) |
Disease < 18 months, N (%) | 53 (60%) |
mRSS, mean (SD) | 22.45 (7.65) |
FVC% predicted, mean (SD) | 85.4 (15.10) |
DLCO% predicted, corrected for Hgb, mean (SD) | 78.0 (18.24) |
Patient global assessment, mean (SD) [theoretical range 0–10] | 4.09 (2.38) |
HAQ-DI, mean (SD) [theoretical range 0–3] | 1.05 (0.71) |
Physician global assessment, mean (SD) [theoretical range 0–10] | 4.77 (1.67) |
Tendon friction rubs, N (%) | 32 (36%) |
Large joint contractures, N (%) | 63 (72%) |
Swollen joint count, mean (SD) [theoretical range 0–28] | 3.75 (5.70) |
Proportion of participants with ≥ 1 swollen joint count, N (%) | 42 (48%) |
Previous use of immunosuppressives, N (%) | 12 (14%) |
Use of prednisone, N (%) | 12 (14%) |